Testing for aldosterone levels may hold the key to treatment-resistant hypertension and many other cardiac conditions, but ...

FDA turns up the heat: Federal regulators are requesting more safety information from drugmakers on products meant to protect ...

The Food and Drug Administration has launched a safety review of two approved RSV drugs for infants, the latest immunizations ...

AstraZeneca PLC is rated a Buy due to strong growth, prudent R&D reinvestment, low leverage and resilience. Learn more about ...

AstraZeneca today announced a strategic regional collaboration with the Middle East North Africa Committee for Treatment and ...

Eli Lilly's innovation and pipeline diversification support long-term growth, despite patent risks and competition. Read more ...

President Donald Trump just announced deals with drugmakers Eli Lilly and Novo Nordisk that will yield lower prices for GLP-1 ...

Home to 4.8 billion people or 60 percent of the world’s population, Asia accounts for 50 percent of the global cancer ...

AstraZeneca PLC (NASDAQ:AZN), the British pharmaceutical company best known for its COVID-19 drug, was at the center of analyst action on December 9th after a report from TD Cowen.

The pharmaceutical company AstraZeneca can move forward with an addition to one of the buildings on its Frederick campus, ...

AstraZeneca PLC (NASDAQ:AZN) is one of the best pharma stocks to invest in. AstraZeneca PLC (NASDAQ:AZN) received a rating ...

At this year's ASH congress, the results of the phase 1b/2 DURGA-1 of AZD0120 – a dual BCMA and CD19-directed CAR-T therapy – ...